Alzamend Neuro Inc.

05/05/2022 | Press release | Distributed by Public on 05/05/2022 06:05

Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s